Android app on Google Play

West Pharmaceutical (WST) Tops Q4 EPS by 5c; Issues Strong FY13 Outlook

February 21, 2013 7:27 AM EST Send to a Friend
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.61, $0.05 better than the analyst estimate of $0.56. Revenue for the quarter came in at $321.5 million versus the consensus estimate of $318.75 million.

West Pharmaceutical Services, Inc. sees FY2013 EPS of $2.97-3.17, versus the consensus of $3.00. West Pharmaceutical Services, Inc. sees FY2013 revenue of $1.36-1.40 billion, versus the consensus of $1.32 billion.

For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.




You May Also Be Interested In


Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment